Personalized Medicine Approach in Treating Parkinson’s Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice

Background: The most effective symptomatic treatment in Parkinson’s disease (PD) is levodopa in standard doses. However, as the disease progresses, there may be a need for a more personalized approach and fine tuning, in accordance with the patients’ needs. This study aims to evaluate the individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Grétarsdóttir, Helga María, Widman, Erik, Johansson, Anders, Nyholm, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400411/
https://www.ncbi.nlm.nih.gov/pubmed/34442364
http://dx.doi.org/10.3390/jpm11080720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400411/
https://www.ncbi.nlm.nih.gov/pubmed/34442364
http://dx.doi.org/10.3390/jpm11080720

Ejemplares similares